explore -WSS

explore

author：comprehensive 2025-09-14 21:46:03 - browse：32

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Campaign finance charge dropped from case against Sam Bankman

entertainment

WSS

'Weather

Europe is fastest

Campaign finance charge dropped from case against Sam Bankman

House GOP plan to stem drug shortages differs from Democrats’

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

entertainment

explore

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Poland's lawmakers approve a divisive law on Russian influence

ChatGPT in medicine: STAT answers readers' burning questions

Adidas to release second batch of Yeezy sneakers after breakup with Ye

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

House GOP plan to stem drug shortages differs from Democrats’

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Peter Hotez and the public health issue of online harassment

Campaign finance charge dropped from case against Sam Bankman

focus

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Doctors increasingly discourage vaping amid mounting health concerns

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

Adidas to release second batch of Yeezy sneakers after breakup with Ye

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

explore

entertainment

hotspot

entertainment